-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Deciphera Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
- Deciphera Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$45.1M, a 9.12% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$190M, a 4.8% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$195M, a 8.93% decline from 2022.
- Deciphera Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$179M, a 40.3% increase from 2021.
- Deciphera Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$300M, a 12.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)